# SignPath Pharma, Inc.: Form D filings

SignPath Pharma, Inc., a pharmaceuticals company in Sandy, UT, filed 12 Form D notices with the SEC between 2009 and 2021. The latest, on May 12, 2021, reports $1.6 million sold of a $11 million offering to 18 investors.

Find out what SignPath Pharma, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20SignPath%20Pharma%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=SignPath%20Pharma%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fsignpath-pharma-inc-1455694)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20SignPath%20Pharma%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=SignPath%20Pharma%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fsignpath-pharma-inc-1455694)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Utah](https://specstream.ai/data/form-d/state/utah): 660 rows, by operating companies, filed since November 1, 2024, $33, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/utah
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 7984 South 1300 East, Sandy, UT, 84094
- Phone: (801) 245-0313
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1455694

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| May 12, 2021 | New notice | $11,000,000 | $1,561,000 | $9,439,000 | 18 | Jun 1, 2020 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1455694/000147793221003027/0001477932-21-003027-index.htm) |
| Aug 28, 2020 | New notice | $10,000,000 | $525,000 | $9,475,000 | 5 | Jun 1, 2020 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1455694/000147793220005225/0001477932-20-005225-index.htm) |
| Dec 18, 2017 | New notice | $5,000,000 | $235,000 | $4,765,000 | 4 | Nov 30, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1455694/000149315217014716/0001493152-17-014716-index.htm) |
| Jul 15, 2016 | New notice | $5,000,000 | $245,000 | $4,755,000 | 8 | Mar 31, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1455694/000149315216011567/0001493152-16-011567-index.htm) |
| Jan 27, 2016 | Amendment | $3,000,000 | $2,359,076 | $640,924 | 36 | Oct 31, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1455694/000149315216006985/0001493152-16-006985-index.htm) |
| Nov 26, 2014 | New notice | $5,000,000 | $320,000 | $4,680,000 | 3 | Oct 31, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1455694/000114420414071232/0001144204-14-071232-index.htm) |
| Jun 5, 2014 | Amendment | $5,000,000 | $4,355,500 | $644,500 | 14 | Mar 13, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1455694/000109690614000772/0001096906-14-000772-index.htm) |
| Mar 22, 2013 | New notice | $5,000,000 | $1,000,000 | $4,000,000 | 1 | Mar 13, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1455694/000109690613000369/0001096906-13-000369-index.htm) |
| May 4, 2012 | Amendment | $3,000,000 | $1,304,000 | $1,696,000 | 26 | Sep 2, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1455694/000109690612001193/0001096906-12-001193-index.htm) |
| Oct 4, 2011 | New notice | $3,000,000 | $580,000 | $2,420,000 | 9 | Sep 2, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1455694/000109690611002306/0001096906-11-002306-index.htm) |
| Jun 1, 2010 | New notice | $2,700,000 | $25,000 | $2,675,000 | 1 | May 12, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1455694/000148912410000001/0001489124-10-000001-index.htm) |
| Mar 5, 2009 | New notice | $1,000,000 | $0 | $1,000,000 | 3 | Feb 19, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1455694/000145569409000001/0001455694-09-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Robert Seguso | Executive Officer, Director |  |
| Peter Sordillo | Executive Officer |  |
| Arthur Ballon, Ph.D | Executive Officer, Director |  |
| Kai Larson | Executive Officer, Director |  |
| Timothy Touloukian | Executive Officer |  |

[Every Form D from the week of May 10, 2021](https://specstream.ai/data/form-d/week/2021-05-10) · [All recent filings in Utah](https://specstream.ai/data/form-d/state/utah) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what SignPath Pharma, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).